Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price hit a new 52-week low on Wednesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.50 ($0.02), with a volume of 2272402 shares traded. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Trading Down 9.1 %
The stock has a market capitalization of £5.91 million, a price-to-earnings ratio of -2,093.22 and a beta of 0.38. The stock has a 50-day moving average price of GBX 1.77 and a 200 day moving average price of GBX 1.85.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- What Are Some of the Best Large-Cap Stocks to Buy?
- Energy Transfer: Powering Data With Dividends and Diversification
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Qualcomm Stock Is Coiling for a Breakout
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
